Clinical Trial Update: Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

This report summarizes a Phase 3 trial comparing the fixed-ratio insulin glargine/lixisenatide combination with insulin glargine in adults with Type 2 diabetes,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• Soliqua (insulin glargine/lixisenatide) (insulin glargine/lixisenatide)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2017-02-10